[Perioperative cardiovascular evaluation and management for noncardiac surgery].
As a population ages, an increase in the number of patients with cardiac complications who undergo non-cardiac surgeries is observed. The perioperative mortality for noncardiac surgery is approximately 1-5%; approximately 20-35% of these cases are due to cardiovascular complications. Among them, perioperative myocardiac infarction/ischemia is a factor that leads to poor prognosis, and the ACC/AHA guidelines emphasize this aspect. An important task of the anesthesiologist is to accurately assess risks in patients undergoing noncardiac surgeries and avoid adverse cardiovascular events.
Yuko
Y
Furuichi
Atsuhiro
A
Sakamoto
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000758:Anesthesia; D001262:Atenolol / Q000008:administration & dosage; D017298:Bisoprolol / Q000008:administration & dosage; D005229:Fatty Acids, Monounsaturated / Q000008:administration & dosage; D000077340:Fluvastatin; D006801:Humans; D007211:Indoles / Q000008:administration & dosage; D007431:Intraoperative Complications / Q000517:prevention & control*; D008790:Metoprolol / Q000008:administration & dosage; D016343:Monitoring, Intraoperative; D009025:Morpholines / Q000008:administration & dosage; D009203:Myocardial Infarction / Q000517:prevention & control*; D017202:Myocardial Ischemia / Q000517:prevention & control*; D019990:Perioperative Care; D011183:Postoperative Complications / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D014508:Urea / Q000008:administration & dosage / Q000031:analogs & derivatives
D000319:Adrenergic beta-Antagonists; D005229:Fatty Acids, Monounsaturated; D007211:Indoles; D009025:Morpholines; D000077340:Fluvastatin; D001262:Atenolol; C077049:landiolol; D014508:Urea; D008790:Metoprolol; D017298:Bisoprolol